News Source: Androscoggin News
| 2 months ago
The difference in PFS correlated with a median survival of 16.8 months in the maintenance group vs...About Telik Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to...
News Source: Uinta County News
| 2 months ago
In June 1989 Amgen, a small biotechnology company in Thousand Oaks, Calif., gained U.S. Food and Drug Administration approval to market its first product, epoetin alfa (Epogen), to treat the anemia that accompanies end-stage kidney failure.